Surgical Stapling Devices Market Report 2026

Surgical Stapling Devices Market Overview

• Surgical Stapling Devices market size has reached to $4.51 billion in 2025 • Expected to grow to $7.34 billion in 2030 at a compound annual growth rate (CAGR) of 10.3% • Growth Driver: The Surge In Chronic Diseases Fuels Growth In The Surgical Stapling Devices Market • Market Trend: Technological Advancements In Surgical Stapling Devices With The Rise Of 3D-Stapling Technology • North America was the largest region in 2025 and Asia Pacific is the fastest growing region.

What Is Covered Under Surgical Stapling Devices Market?

Surgical stapling devices refer to medical devices used for internal surgical operations such as removing a portion of an organ and tissues and creating connections between sutures. It can repair serious wounds or cuts faster and are less uncomfortable for patients than stitches. They are frequently employed in minimally invasive surgery. The main product types of surgical stapling devices are powered and manual. Manual surgical stapling devices refer to staplers that the surgeon needs to apply his skills to variable grip force to push the knife blade, and staples to treat large wounds or surgical cuts on a patient's skin or scalp that are closed outside the body. The various surgery types include open surgery and laparoscopic surgery. These are used in various applications such as gynecology surgery, urology surgery, and general surgery, among others, and also used by various end-users such as hospitals, ambulatory surgical centers, and others.

What Is The Surgical Stapling Devices Market Growth Forecast?

The surgical stapling devices market size is expected to see rapid growth in the next few years. It will grow to $7.34 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to growing demand for powered and rechargeable staplers, expansion of minimally invasive surgery volumes, increasing focus on reducing surgical time, advancements in stapler cartridge technology, rising adoption in outpatient surgical settings. Major trends in the forecast period include increasing adoption of powered surgical staplers, rising use of minimally invasive stapling techniques, growing demand for disposable and single-use staplers, expansion of ergonomic stapler designs, enhanced focus on surgical precision and safety.

Global Surgical Stapling Devices Market Segmentation

1) By Product: Powered, Manual 2) By Surgery Type: Open Surgery, Laparoscopic Surgery 3) By Application: Gynecology Surgery, Urology Surgery, General Surgery, Other Applications 4) By End-User: Hospitals, Ambulatory Surgical Centers, Other End -Users Subsegments: 1) By Powered: Powered Staplers, Rechargeable Powered Staplers, Battery-Operated Staplers 2) By Manual: Manual Staplers, Disposable Manual Staplers, Reusable Manual Staplers

What Is The Driver Of The Surgical Stapling Devices Market?

The rising incidence of chronic diseases is expected to propel the growth of the surgical stapling devices market in the coming future. Chronic illnesses are long-term medical disorders that often develop gradually and last for a long time, often the entirety of an individual's life. Surgical stapling instruments are used in procedures that target or are connected to chronic disease-related problems or symptoms. For instance, in April 2024, according to Allergy UK, a UK-based national charity, more than 21 million people in the UK are affected by allergies, which became the most commonly reported chronic health condition in 2022, and projections indicate that by 2026, half of Europe's population will experience at least one allergy. Therefore, the rising incidence of chronic diseases is driving the surgical stapling devices industry.

Key Players In The Global Surgical Stapling Devices Market

Major companies operating in the surgical stapling devices market are 3M Company, Medtronic PLC, Johnson & Johnson MedTech, Becton Dickinson and Company, Stryker Corporation, B. Braun SE, Zimmer Biomet Holdings Inc., Intuitive Surgical Inc., Smith & Nephew PLC, Teleflex Incorporated, CONMED Corporation, Meril Life Sciences India Pvt. Ltd., Blue Sail Medical Co Ltd., Surgical Specialties Corporation, Ackermann Instrumente GmbH, Frankenman International Ltd., Touchstone International Medical Science Co. Ltd., Genesis Medtech Group., Jiangsu Qianjing Medical Equipment Co. Ltd., Purple Surgical Holdings Limited, Surgical Innovations Group, BioPro Inc., Changzhou Ankang Medical Instruments Co. Ltd., Dextera Surgical Inc., Cardica Inc., Grena Ltd., Welfare Medical Ltd., Lexington Medical Inc., Advin Healthcare Private Limited (AHPL), Victor Medical Instruments Co. Ltd.

Global Surgical Stapling Devices Market Trends and Insights

Major companies operating in the surgical stapling devices market are adopting new technologies, such as 3D-stapling technology, to improve precision, enhance tissue healing, and reduce complications during surgical procedures. 3D-stapling technology is an advanced surgical stapling method designed to improve the precision and effectiveness of tissue closure during surgeries. For instance, in May 2024, Ethicon Inc., a US-based surgical technologies company, launched the ECHELON LINEAR Cutter, a surgical stapler designed to enhance surgical outcomes by significantly reducing the risk of leaks at the staple line. This cutter is particularly vital in colorectal surgeries, where anastomoses (the connection of two ends of the colon) are critical. ECHELON LINEAR Cutter features 3D-Stapling Technology that utilizes offset staple legs that distribute tissue compression evenly, improving staple line integrity and reducing potential leak pathways. This device also features Gripping Surface Technology (GST), which stabilizes and compresses tissue effectively, minimizing slippage during procedures, which is crucial for maintaining staple line security.

What Are Latest Mergers And Acquisitions In The Surgical Stapling Devices Market?

In August 2024, Vantedge Medical, a US-based provider of precision manufacturing solutions for medical devices, acquired Hobson & Motzer for an undisclosed amount. With this acquisition, Vantedge aims to expand its consumable device portfolio, enhance its precision manufacturing capabilities, and strengthen its position as a nationwide supply partner to leading medical technology OEMs. Hobson & Motzer is a US-based manufacturer of precision medical components for the surgical stapler, offering automated progressive stamping, electrochemical machining, coined wire, and advanced tool-and-die capabilities.

Regional Outlook

North America was the largest region in the surgical stapling devices market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Surgical Stapling Devices Market?

The surgical stapling devices market consists of sales of circular staplers, skin staplers, and open staplers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.